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Background: Co production of 16S rRNA methylases gene and b-Lactamase gene among Enterobacteriaceae
isolates conferring resistance to both therapeutic options has serious implications for clinicians worldwide.
Methods: To study co existence of 16S rRNA methylases (armA, rmtA, rmtB, rmtC, rmtD, and npmA) and
b-Lactamase (blaTEM-1, blaSHV-12, blaCTX-M-14) genes, we screened all phenotypic positive b-Lactamase
producing enterobacteriaceae by polymerase chain reaction (PCR) targeting above genes. A total of 330
enterobacteriaceae strains were collected during study period out of that 218 isolates were identified
phenotypically as b-Lactamase producers, which include 50 (22.9%) Escherichia coli; 92 (42.2%) Klebsiella
pneumoniae, 44 (20.2%), Citrobactor freundii and 32 (14.7%) Enterobacter spp.
Results: Among this 218, only 188 isolates harbored the resistant gene for b-Lactamase production. Major
b-Lactamase producing isolates were blaTEM-1 type. 122 (56 %) isolates were found to produce any one of the
16S rRNA methylase genes. A total of 116 isolates co produced b-Lactamase and at least one 16S rRNA
methylases gene Co production of armA gene was found in 26 isolates with rmtB and in 4 isolates with rmtC.
The rmtA and rmtD genes were not detected in any of the tested isolates. Six isolates were positive for a 16S
rRNA methylase gene alone.
Conclusion: b-Lactamase producing isolates appears to coexist with 16S rRNA methylase predominantly
armA and rmtB genes in the same isolate. We conclude the major b-Lactamase and 16S rRNA methylases
co-producer was K. pneumoniae followed by E. coli. We suggest further work on evaluating other
b-lactamases types and novel antibiotic resistance mechanisms among Enterobacteriaceae.
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T
he widespread use of antibacterial drugs has re-
sulted in the emergence of multidrug and pan-drug
resistant Gram negative bacterial strains, which
pose challenges in an era when new antibiotic choices are
limited (1, 2). Multidrug resistant strains are intermediate
or resistant to at least three drugs in the classes of b-
lactams, carbapenems, aminoglycosides, and fluoroquino-
lones, whereas pan-drug resistant strains are treatable
only with a colistin (3). Pan-drug resistant pathogens with
acquired resistance to almost all available antimicrobial
agents have emerged in recent years and challenged the
treatment of infections (2, 3). Strains in the Entero-
bacteriaceae family have been well documented for their
resistance to clinically used antibiotics (4, 5). Extended
spectrum b-lactamase (ESBL) and metallo b-lactamase
(MBL) production are the commonly recognized resistance
mechanisms in Enterobacteriaceae strains worldwide (6).
Usually, aminoglycosides such as amikacin and to-
bramycin are used to treat infections by Gram nega-
tive pathogens, in combination with b-lactam agents.
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But increasing resistance to aminoglycosides by novel
mechanisms is being reported (7, 8). 16S rRNA methylases
have emerged recently as a mechanism of high level
aminoglycoside resistance to most of the clinically im-
portant aminoglycosides, including arbekacin, amikacin,
tobramycin, and gentamicin (4, 9). In 2003, the first 16S
rRNA methylase gene, armA, was identified. Since then,
eight plasmid-mediated 16S rRNA methylases (armA,
rmtA, rmtB, rmtC, rmtD, rmtE, rmtF, and npmA) have
been found in clinical isolates of Gram negative bacilli
(1012). Recently, rmtD (which was first identified in a
pan-resistant Pseudomonas aeruginosa strain isolated in
Brazil and hitherto only found in Latin America), was
also detected in a Klebsiella pneumoniae isolate in Brazil
(1315). armA and rmtB have been found in many species
of Gram negative bacilli in Asia (4, 16).
Dissemination of b-lactamase producing clinical iso-
lates with acquired 16S rRNA methylase genes has
become a global concern. Unreasonable use of b-lactams,
including cephalosporins, carbapenams, and aminoglyco-
sides for the treatment of Gram-negative nosocomial
infections has facilitated the emergence of pan-resistant
strains associated with therapeutic failures (3, 4). Coex-
istence of 16S rRNA methylase genes and b-lactamase
genes among Enterobacteriaceae isolates confers resis-
tance to both therapeutic options. This study was
undertaken to determine the prevalent mechanisms of
resistance among b-lactamase positive Enterobacteria-
ceae strains and also to investigate by polymerase chain
reaction (PCR) the coexistence of b-lactamase and 16S




Between January 2011 and December 2011, 330 non-
duplicate Enterobacteriaceae isolates were consecutively
collected from patients at El Iman Hospital, Riyadh:
E. coli, K. pneumoniae, C. freundii, and Enterobactor spp
(E. aerogenes and E. cloacae). The strains were obtained
mostly from urine (72%) and blood (11%), but also from
wounds, sputum, and other body fluids. Identification
of the clinical isolates was confirmed by using GNI cards
on the VITEK-60 system (bioMerieux, Marcy l’Etoile,
France) and conventional methods, namely, Gram stain-
ing, morphology on differential media (MacConkey agar),
and biochemical tests (manitol motility, Mannite, citrate
utilization, indole production, triple sugar ion, and methyl
red and Voges Proskauer tests).
Antimicrobial susceptibility testing
Antimicrobial susceptibilities were determined by using
GNS cards on the VITEK-60 system (bioMerieux, France).
Antimicrobial susceptibility to amikacin, tobramycin,
and gentamicin was confirmed by the disk diffusion test
using commercial disks for cefotaxime, ceftazidime, cipro-
floxacin, levofloxacin, cefoxitin, imipenem, tetracycline,
and trimethoprim/sulfamethoxazole (Himedia, Mumbai,
India) according to the criteria recommended by the
Clinical and Laboratory Standards Institute (CLSI) (17).
Minimum inhibitory concentrations (MICs) of amikacin,
tobramycin, and gentamicin were determined by agar
dilution according to CLSI guidelines and interpretative
criteria. E. coli ATCC 25922, Enterococci ATCC 29212,
and K. pneumoniae ATCC 27853 were used as quality
control strains for antimicrobial susceptibility testing.
Phenotypic identification of b-lactamase strains
b-Lactamase-producing strains were identified by resis-
tance to third generation cephalosporins by using a
VITEX-60 system (bioMerieux) and by production of
b-lactamase utilizing the confirmatory double-disk com-
bination test (17). K. pneumoniae ATCC 700603 was used
as the b-lactamase positive control. b-lactamase pro-
ducers were further characterized for the presence of
different b-lactamase genes.
Extraction of total DNA from b-lactamase-producing
strains
Whole genomic DNA was extracted from colonies grown
overnight (1416 h) at 378C on blood agar (Remel,
Lenexa, KS) using the QIAamp DNA Mini Kit and
the QIAcube instrument (Qiagen, Valencia, CA) accord-
ing to the manufacturers’ instructions. Total DNA was
extracted and stored at 208C for further assays.
Genotypic characterization of b-lactamase and
16S rRNA methylase genes
bla genes were detected in b-lactamase-producing isolates
by PCR using the previously reported oligonucleotide
primers for blaTEM-1, blaSHV-12, blaCTX-M-14 (18), and the
armA, rmtA, rmtB, rmtC, rmtD, and npmA genes by using
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Sequencing analysis of multiplex PCR products
Isolates positive for bla or 16S rRNA methylase genes
were identified by PCR. The identities of the genes were
confirmed by DNA sequencing on an ABI PRISM 3730
automated sequencer (Applied Biosystems, Foster City,
CA) following the standard protocol, and the sequences
were compared with those in the GenBank nucleotide
database at http://www.ncbi.nlm.nih.gov/blast/. There-
after, positive isolates were used as positive controls for
the rest of the respective PCR reactions.
Results
Of the 330 isolated strains of Enterobacteriaceae, 218
isolates were identified as b-lactamase producers by the
double-disk combination test: 50 (22.9%) E. coli, 92
(42.2%) K. pneumoniae, 44 (20.2%) C. freundii, and 32
(14.7%) Enterobacter spp. All 330 isolates showed the
highest resistance to ciprofloxacin (70%) followed by
tobramycin (68%), gentamicin (58%), aztreonam (57%),
amikacin (54%), and co-trimoxazole (54%). A signifi-
cantly higher resistance to nitrofurantoin was seen in
K. pneumoniae strains (82%) than in E. coli (24%). Strong
resistance was noted for carbapenems: meropenem (49%)
and imipenem (38%). Most of the isolates were suscep-
tible to colistin (95%) and tigecycline (93%). MIC values
of all 330 isolates were ]16 mg/ml for gentamicin and
tobramycin, and more than 32 mg/ml for amikacin.
b-Lactamase characterization
The major b-lactamase-producing isolates were of the
blaTEM-1 type: at least one blaTEM-1 gene was present in
83.5% (182/218) of the isolates. All 218 isolates of E. coli
and K. pneumoniae possessed one or more b-lactamase
gene, whereas 14 of the C. freundi and 16 Enterobacter
spp were negative for all tested b-lactamase genes.
In total 70 isolates (32%) harbored only blaTEM-1: 26
E. coli and 44 K. pneumoniae. We detected the presence
blaTEM-1 in combination with blaCTX-M-14 in 51% of
the isolates (111/218) and in combination with blaSHV-12
in 39.4% (86/218). Other important combinations were
blaCTX-M-14blaTEM-1blaSHV-12 (39%; n85) and
blaCTX-M-14blaTEM-1 (12%; n26) (Table 1).
16S rRNA methylase characterization of b-lactamase
Among the 218 isolates, 122 isolates (56%) were found
to produce 16S rRNA methylase genes, including 24
E. coli, 52 K. pneumoniae, 30 Citrobacter, and 16
Enterobacter spp. armA, rmtB, rmtC, and npmA were
found exclusively in 72, 10, 6, and 4 isolates, respectively.
armA coexisted with rmtB in 26 isolates and with rmtC in
4 isolates. rmtA and rmtD were not detected in any of the
isolates (Table 2).
Coexistence of b-lactamase and 16S rRNA
methylase genes
A total of 116 isolates harbored both b-lactamase and
16S rRNA methylase genes, including 24 E. coli, 52
K. pneumoniae, 26 C. freundi, and 14 Enterobactor spp.
Six isolates were positive for 16S rRNA methylase genes
alone. Sixty-six b-lactamase-producing isolates did not
harbor any methylase genes (Tables 3 and 4).
Discussion
We noted that almost all (83.5%) Enterobacteriaceae
isolates were b-lactamase positive. This rate is even higher
than reported in some other developing countries
(6070%) (2, 5, 13, 22). By contrast, the prevalence of
ESBL-producing isolates among Enterobacteriaceae in
developed nations is much lower:B1% in Sweden (23)
and 1.7% in France (24). One review reported that the
prevalence of ESBLs in Europe was higher than in the US
but much lower than in Asia and South America (25).
This issue is evidently a challenge in developing nations,
and our study clearly shows that it is a matter of urgency
in our region.
The isolates were tested only for the bla genes reported
to be prevalent in this region (26) (blaCTX-M-14blaTEM-1
and blaSHV), and 83.5% of them were positive for
blaTEM-1. An Indian study (2) reported that 61.1% of MBL
producers carried bla(VIM) and 2 (3%) carried bla(IMP).
However, in our study we did not examine these two
genes but only the major ESBL genes. This is probably
the reason why some phenotypically b-lactamase positive
isolates were genotypically negative for bla genes.





likeCTX-M 14 bla negative* Total
E. coli 26 3 1 20 00 50
K. pneumoniae 44 9 0 39 00 92
C. freundi 0 10 0 16 14 44
Enterbacter 0 4 0 10 18 32
Total 70 26 1 85 36** 218
*bla-negative isolates are attributed to presence of bla genes other than those analyzed.
**Six isolates were postive for 16S rRNA methylase genes (armA and rmtB).
16S rRNA methylase genes in b-lactamase producers
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Previous study showed that the most prevalent micro-
organism was E. coli, followed by K. pneumonia, and
other Enterobacteriaceae (5, 6, 21, 27). A study from
France in 2008 reported that the most prevalent species
were E. coli (48.5%), Enterobacter aerogenes (23.7%), and
K. pneumoniae (14.8%) (24). In our study, the contribu-
tion of K. pneumonia to the b-lactamase strains was
higher (42.2%, 92/218), whereas that of E. coli was lower
(22.9%, (50/218). Noteworthy, most of the isolates (72%)
were obtained from urinary tract specimens, and they
showed strong resistance to aminoglycosides (amikacin,
tobramycin, and gentamicin), thus limiting the treatment
options.
b-Lactamase-producing Enterobacteriaceae often har-
bor other genes (ampC, MBL, and 16S rRNA methylase
genes) that confer resistance to other antibiotics, includ-
ing carbapenams, cephems, and aminoglycosides (3, 4, 9).
16S rRNA methylase genes have been reported worldwide
in Enterobacteriaceae, P. aeruginosa and Acinetobacter
baumannii (4, 14, 16, 28). A previously published report
suggested the spread of armA and rmtB in Enterobacte-
riaceae isolates globally (29), and these genes were often
reported to coexist with other resistance determinants,
such as bla and MBL genes (12, 13, 30, 31). Newer 16S
ribosomal RNA methylases have been identified recently
and added to the database of aminoglycoside resistance
mechanisms (4, 14, 16).
Only a few studies are available on the prevalence of
16S rRNA methylase genes in clinical Enterobacteriaceae
isolates in our region (4). Therefore, we investigated and
characterized the association of 16S rRNA methylase
genes with b-lactamase genes among clinical Enterobac-
teriaceae isolates in a Saudi hospital. We observed that
the coexistence of the 16S rRNA methylase genes and
b-lactamase was very common: 56% of isolates that were
genotypically positive for b-lactamase possessed one of
the 16S rRNA methylase genes, predominantly armA.
This rate is higher than those reported in a Taiwanese
Table 3. Coexistence of bla genes with different 16S rRNA
methylase genes in isolates phenotypically positive for b-
lactamase











armArmt B only 2
Positive for bla gene but no 16S rRNA detected but 66
No bla gene or 16S rRNA methylase gene detected* 30
Total 218
*Negative isolates may attributed to presence of bla or methylase
genes that were not analyzed in this study.
Table 4. Coexistence of 16S rRNA genes with different
ESBL genes in isolates phenotypically positive for b-
lactamase
Positive for gene n
TEM-1SHV 12 likeCTX-M 1416S rRNA methylases 64
TEM-1CTX-M 1416S rRNA methylases 23
TEM-1SHV 12 likeCTX-M 1416S rRNA methylases 10
TEM-1SHV 12 likeCTX-M 1416S rRNA methylases 6
TEM-116S rRNA methylases 4
TEM-1SHV 12 likeCTX-M 1416S rRNAmethylases 4
TEM-1CTX-M 1416S rRNA methylases 3
TEM-1SHV 12 like 1
TEM-116S rRNA methylases 1
TEM-1SHV 12 likeCTX-M 1416S rRNA methylases 1
TEM-1 only 65
Positive for 16S rRNA but no bla gene detected 6
No bla or 16S rRNA methylase gene detected* 30
Total 218
*Negative isolates may be attributed to presence of bla or
methylase genes that were not analyzed in this study.
Table 2. Coexistence of different 16sRNA methylase genes in isolates phenotypically positive for b-lactamase
armA rmt B rmt C npmA armArmtB armArmtC arm negative* Total
E. coli 16 2 2 0 2 2 26 50
K. pneumoniae 34 6 0 2 8 2 40 92
C. freundi 16 2 0 0 12 0 14 44
Enterobacter 6 0 4 2 4 0 16 32
Total 72 10 6 4 26 4 96 218
*Isolates negative for 16S rRNA methylase genes may be attributed to absence of methylase genes or to presence of methylase genes
other than those that were analyzed in this study, such as rmtE and rmtF.
Yazeed A. Al Sheikh et al.
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study (21) and a Belgian study (28). But like previous
reports (4, 16, 28), we also observed greater prevalence
of armA than rmtB. We also report the presence of
rmtC in four E. coli and four Enterobacter isolates. It is
noteworthy that we identified npmA in two K. pneumoniae
and two Enterobacter isolates. This is a novel finding in
this region, because rmtC and npmA have been detected
in Proteus mirabilis and E. coli, respectively, in Japan
(13, 20). We did not detect any rmtA or rmtD gene in
our isolates.
In agreement with previous reports (26, 32), b-lactamase
positive isolates were more susceptible to colistin and
tigecycline, which were the only available therapeutic
options for them.
In our study, 35.2% (64/182), 5.5% (10/182), 3.3%
(6/182), and 2.2% (4/182) of the isolates harboring
blaTEM-1 also contained armA, rmtB, rmtC, and npmA,
respectively, in association with blaTEM-1SHV 12 like
CTX-M 14. One isolate produced armA and rmtB along
with blaTEM-1SHV 12 likeCTX-M 14. This points to
horizontal as well as clonal dissemination of these genes
in our hospital. We also found strains harboring two dif-
ferent 16S rRNA methylase genes in combinations, in-
cluding two strains carrying armArmtB and one strain
carrying armArmtC.
In conclusion, b-lactamase-producing isolates of En-
terobacteriaceae were common in our hospital and they
usually harbored 16S rRNA methylase genes, predomi-
nantly armA and rmtB. The major co-producers of b-
lactamase and 16S rRNA methylases were K. pneumonia,
followed by E. coli. Our findings underline the emerging
threat of pan-drug resistant pathogens that produce both
b-lactamase and 16S rRNA methylase disseminating in
this region. Further work to evaluate other b-lactamase
types and novel antibiotic resistance mechanisms among
Enterobacteriaceae and other nosocomial pathogens is
needed.
Acknowledgements
The authors extend their sincere appreciation to the Deanship of
Scientific Research at King Saud University for funding this
research through the Research Group Project No. RGP-VPP-314.
Conflict of interest and funding
The authors certify that there is no financial or other
conflict of interest regarding the material discussed in the
manuscript.
References
1. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D,
et al. Ready for a world without antibiotics? The Pensières
Antibiotic Resistance Call to Action. Antimicrob Resist Infect
Control. 2012; 1: 11.
2. Arunagiri K, Sekar B, Sangeetha G, John J. Detection and
characterization of metallo-beta-lactamases in Pseudomonas
aeruginosa by phenotypic and molecular methods from clinical
samples in a tertiary care hospital. West Indian Med J. 2012; 61:
77883.
3. Kashanian J, Hakimian P, Blute M, Jr, Wong J, Khanna H,
Wise G, et al. Nitrofurantoin: the return of an old friend in the
wake of growing resistance. BJU Int. 2008; 102: 16347.
4. Krishnappa LG, John J, Marie MAM, Gopalkrishnan S,
Pradeep CS, Rani SRB. Detection of pan-amino glycoside-
resistant Gram negative bacteria using a molecular method.
South Asian J Exp Biol. 2012; 2: 2568.
5. Sahni RD, Balaji V, Varghese R, John J, Tansarli GS, Falagas
ME. Evaluation of fosfomycin activity against uropathogens in
a fosfomycin-naive population in South India: a prospective
study. Future Microbiol. 2013; 8: 67580.
6. Mammina C, Di Carlo P, Cipolla D, Giuffrè M, Casuccio A,
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